America Must Wake Up and Fire the Under-performers

The United States stands at a precipice. Citizens sense it in their bones—even when the evening news tries to soothe them with distractions. Our two-party system has hardened into a theatre of underperformance, a duopoly addicted to power, not progress.

Every election cycle, we’re told to choose “the lesser of two evils,” as if destiny must forever be tethered to lawmakers and enforcement officers who promise reform with one hand and preserve the status quo with the other. Meanwhile, we—the stakeholders—fund salaries, pensions, and privileges while our schools age, our healthcare groans, and trust erodes.

From Cradle to Grave: Who Pays the Price?

When lawmakers underperform, the cost isn’t theoretical—it is generational.

The Unborn: Babies not yet born inherit trillions in debt and an overheated planet. Policy neglect locks them into futures of scarcity before they take their first breath.
Children: Underfunded schools, unsafe neighbourhoods, and eroding nutrition programs leave millions without a fair start. A child’s zip code should not dictate their destiny.
Working Adults: Stagnant wages, unaffordable healthcare, and predatory credit structures leave families trapped in cycles of stress. Innovation is stifled when survival consumes creativity.
The Elderly: Seniors face fragile pensions, unaffordable prescriptions, and care facilities understaffed to dangerous levels. The dignity of our aged becomes the collateral damage of budget games.

Every generation feels the strain. Underperformance is not abstract—it is visible in empty grocery carts, delayed prescriptions, unpaved streets, and rising suicide rates.

Lessons History Keeps Teaching

Great nations have fallen not by invasion, but by rot within. Rome’s Senate ignored the cries of its people. France’s aristocracy danced while bread riots spread. More recently, the Soviet Union collapsed under the weight of inefficiency and denial. America should not delude itself—it is not immune to the laws of history.

Every unkept promise, every shrug at corruption, every partisan stalemate pushes the country closer to the brink where cynicism replaces civic faith. And once citizens no longer believe their vote matters, democracy itself begins to decay.

What Citizens Can—and Must—Do

Accountability is not a spectator sport. Here are practical actions Americans can take:

Fire with your vote: Track performance like a manager would. If your representative fails measurable goals—vote them out.
Audit the money: Follow the donor trail. If corporations and lobbyists outweigh citizens in influence, redirect your vote accordingly.
Local first: Start with school boards, city councils, sheriffs. These positions impact your daily life more than Congress, yet often go uncontested.
Use recalls & referenda: Where laws allow, petition to recall under-performers or pass initiatives directly.
Show up: Attend public meetings, demand records, write public comments. A room of 20 engaged citizens can change an entire policy direction.

The Cost of Doing Nothing

If citizens do nothing, the impacts compound:

National debt snowballs, shackling unborn generations to interest payments rather than investments in education or climate resilience.
Healthcare collapses further, leaving lives shortened not by disease, but by inaccessibility.
Communities fracture under distrust—between races, classes, and neighbours—because leadership refuses to address root causes.
Global influence wanes; allies lose trust, and adversaries exploit paralysis.

Inaction is not neutral. It is a choice with devastating consequences.

Renewal Is Possible

But despair is not the only option. Renewal is possible if citizens apply pressure consistently. Look at examples:

1960s Civil Rights Movement: Ordinary citizens marching and voting forced systemic change despite overwhelming opposition.
Post-Watergate reforms: Public outrage delivered campaign finance reforms, greater transparency, and accountability for executive overreach.
Local victories: Cities like Denver and Portland have transformed housing, transit, and climate policies because citizens refused to let leaders coast.

The formula is timeless: persistent civic action + accountability = renewal.

Power is not in the halls of Congress. It is in our hands—if we remember to use it.

FAQ: Citizen Power & Accountability

Is this anti-party?

No. It’s anti-underperformance. Any party that delivers measurable results earns votes; those who don’t, don’t.

What does “fire” mean here?

Lawful accountability: voting out incumbents, backing challengers, supporting recalls where legal, and escalating oversight.

How do I assess performance quickly?

Use a simple scorecard: 3–5 priorities, baseline metrics, and quarter-over-quarter change. Reward doers, not talkers.

The author requested anonymity to focus attention on ideas rather than identity.

‍

The City Must Learn to Live With Water

The modern city has spent more than a century attempting to make water disappear. Rain falls onto roofs, roads and pavements. Gutters collect it. Drains capture it. Pipes bury it. Pumps move it. Rivers are channelled. Wetlands are filled. Coastlines are defended. The engineering objective has largely been straightforward: separate water from urban life as efficiently as possible. That model is reaching its limits. Around 600 million urban residents already live with significant annual flood hazard, according to the World Bank. Globally, 1.81 billion people live in flood-prone areas, while annual urban flood losses could approach $50 billion by 2050. Rapid urbanisation, ageing drainage infrastructure, land subsidence and changing rainfall patterns are interacting with the basic physical reality that cities have covered enormous portions of naturally absorbent ground with concrete and asphalt. Yet the consequential story is not simply that cities need bigger drains. A different philosophy of urban resilience is emerging: parks designed to flood temporarily; streets shaped to carry cloudbursts; wetlands restored as infrastructure; plazas capable of storing stormwater; permeable landscapes that absorb rainfall; buildings elevated or adapted to tolerate inundation; sensors that reveal water movement in real time; and neighbourhoods organised around the understanding that some water cannot — and perhaps should not — be engineered away. The World Bank increasingly describes effective urban flood management as an integration of grey infrastructure, green infrastructure, nature-based systems, planning, warning systems and institutional reform, rather than reliance on any single engineering intervention. The conceptual reversal is enormous. For generations, successful urbanisation meant controlling nature sufficiently to construct the city. The next generation of urbanism may require something more intelligent: designing the city so nature can still function inside it.

The Price of Money Is Becoming Political Again

For much of the post-financial-crisis era, wealthy economies became accustomed to an extraordinary condition: money was cheap. Governments could borrow heavily, companies could finance expansion at modest rates, asset prices could rise on abundant liquidity, and households learned to treat low-cost mortgages as something approaching economic normality. That world is disappearing fast. Across major economies, long-term government borrowing costs have climbed towards levels not seen for years or decades. On 17 August, the US 30-year Treasury yield reached roughly 5.31 per cent, its highest level since 2007. Japan’s 10-year government bond yield subsequently approached 2.95 per cent, a three-decade high, while German borrowing costs have risen to 15-year highs. The OECD describes the present combination of elevated financing requirements and elevated yields as exceptional compared with the previous two decades. Behind those numbers is a larger structural contest. Governments need capital for debt refinancing, defence, infrastructure, pensions, healthcare and climate resilience. Technology companies require extraordinary sums for artificial-intelligence infrastructure. Energy systems require grids, generation and storage. Businesses require investment. Families require mortgages and credit. These demands do not occupy separate universes. They ultimately encounter the same fundamental economic resource: capital. And when many powerful institutions want more of it simultaneously, the price of money stops being an obscure financial-market variable. It becomes a question of who gets financed, at what price, and at whose expense.

Cancer Vaccines Are Becoming Personal

For more than a century, the word vaccine has largely meant prevention: teach the immune system to recognise a threat before disease takes hold. Cancer is forcing medicine to reconsider that architecture. A new generation of experimental therapies is attempting something considerably more individual: sequence a patient’s tumour, identify mutations particular to that cancer, manufacture instructions corresponding to selected tumour-specific targets, and teach the patient’s immune system to recognise what belongs to the cancer growing inside that particular body. On 19 August, Moderna and Merck announced that their Phase III trial of the investigational personalised mRNA therapy intismeran autogene, used with Merck’s checkpoint inhibitor Keytruda after surgery for high-risk melanoma, achieved statistically significant and clinically meaningful improvements in recurrence-free survival and distant-metastasis-free survival compared with Keytruda alone. The global trial enrolled 1,137 patients with resected stage IIB–IV melanoma. No new safety concerns were identified in the announcement. Full detailed Phase III results remain pending. The result matters because this is not simply another medicine administered to everyone carrying the same diagnosis. Intismeran is designed individually. Tumour and normal tissue are sequenced; mutations are analysed computationally; selected neoantigens — abnormal molecular features produced by the tumour — become the targets encoded into an mRNA therapy manufactured for that patient. Earlier Phase IIb evidence provides important context rather than a substitute for the unreleased Phase III detail. At five-year median follow-up, Moderna and Merck reported that intismeran plus Keytruda reduced the risk of recurrence or death by 49 per cent and distant metastasis or death by 59 per cent compared with Keytruda alone in that smaller study. The larger significance therefore extends beyond melanoma. Medicine has spent generations classifying disease so that patients with sufficiently similar conditions can receive sufficiently similar treatments. Personalised cancer vaccines suggest a different possibility: the diagnosis may identify the disease, while the tumour itself helps design the medicine. If that model succeeds across cancers, one of medicine’s great industrial achievements — standardisation — will begin coexisting with its apparent opposite: manufacturing treatment for one.